Clinical trial
A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty
NCT06284941 is registered in ClinicalTrials.gov with Wang wanxia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Ropivacaine Complex Methylene Blue Fascia Iliaca Compartment Block on Analgesia in Patients Undergoing Hip Arthroplasty
- Lead sponsor
- Wang wanxia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 20, 2023
- Completion date
- February 28, 2024
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
femoral neck disease